The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males
- 9 February 2006
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 64 (3), 307-313
- https://doi.org/10.1111/j.1365-2265.2006.02461.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemiaActa Endocrinologica, 2003
- Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergolineJournal of Clinical Endocrinology & Metabolism, 1996
- A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic AmenorrheaNew England Journal of Medicine, 1994
- Ultrastructural Lesions in Testes from Hyperprolactinemic MenJournal of Andrology, 1984
- Effects of Human Chorionic Gonadotropin, Prolactin, and Bromocriptine on Photoperiodinduced Testicular Regression and Recrudescence in Golden HmstersJournal of Andrology, 1980
- Male Hyperprolactinemia: Effects on FertilityFertility and Sterility, 1979
- Clinical Findings and Testicular Histology in Three Hyperprolactinemic Infertile MenFertility and Sterility, 1979
- Prolactin, Growth Hormone, Luteinizing Hormone Receptors, and Seasonal Changes in Testicular Activity in the Golden Hamster*Endocrinology, 1978
- Prolactin-Secreting Tumors and Hypogonadism in 22 MenNew England Journal of Medicine, 1978
- TESTICULAR LH BINDING IN THE HAMSTER: MODIFICATION BY PHOTOPERIOD AND PROLACTIN1Endocrinology, 1977